A unique platform to discover novel peptides that normalize cellular micro-environments

Micro-enviroments in cells become dysregulated with disease progression and prolonged treatments (treatment resistance) 



FIRST THERAPEUTIC TARGETHORMONE-SENSITIVE CANCERSA novel co-treatment for Treatment Resistant Prostate Cancer by normalizing iron dysregulation in PC tumor cells

SITE UNDER CONSTRUCTION